You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指午後未能上企萬七關後升幅收窄 金沙及港交所倒跌約2%
內地9月CPI年升加快至2.8%創近兩年半高,但略低市場預期。恆指承今早由11年低位急彈,下午升幅曾進一步擴至639點或3.9%報17,028遇阻,現報16,807僅回升418點或近2.6%,總成交額710億元。此外,恆生科指午後升幅一度擴大至5.1%高見3,318也遇阻,現報3,258,僅反彈3.2%。 藍籌股幾乎全面造好,尤其是受惠連日回購藥明生物(02269.HK)股價三連升,午後升幅曾擴至16%高見54.5元,現報52.6元,急漲12%。藥明康德(02359.HK)料首季盈餘倍增,午後股價升幅曾擴至13%高見71.45元,現報69.2元,急漲9.6%。藍籌中生製藥(01177.HK)高見4元,現報3.95元,回升7.6%。石藥(01093.HK)三連升,股價升破50天及百天線,最高見8.24元,現報8.16,續升5.7%。 金融股以受惠鎊匯重越1.1關之上的匯控(00005.HK)升幅最大,股價重越10天線,曾漲逾6%高見41.3元,現報40.7元,升5%;友邦(01299.HK)由曾漲逾5%至70.1元,收窄至僅升3.3%報68.85元。 碧服(06098.HK)由近四年半低位急彈,午後曾漲10%高見9.97元,現報9.77元,回升8%;母企碧桂園(02007.HK)及龍湖(00960.HK)彈逾4%,分別高見1.48元及19.76元。此外,信義玻璃(00868.HK)及信義光能(00968)升逾5%及7%曾分別高見11.84元及8.26元。 然而,港交所(00388.HK)繼今早彈至264元無以為繼後,午後掉頭見254元,現報253元,續跌2.1%。中電(00002.HK)、百威亞太(01876.HK)及金沙中國(01928.HK)也倒跌0.4%-1.8%,金沙中國由今早高位17.24元,掉頭續跌1.8%報16.44元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account